136 related articles for article (PubMed ID: 12014814)
1. Treatment of heroin dependence with buprenorphine in primary care.
Fiellin DA; Pantalon MV; Pakes JP; O'Connor PG; Chawarski M; Schottenfeld RS
Am J Drug Alcohol Abuse; 2002; 28(2):231-41. PubMed ID: 12014814
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.
O'Connor PG; Oliveto AH; Shi JM; Triffleman EG; Carroll KM; Kosten TR; Rounsaville BJ; Pakes JA; Schottenfeld RS
Am J Med; 1998 Aug; 105(2):100-5. PubMed ID: 9727815
[TBL] [Abstract][Full Text] [Related]
3. A trial of integrated buprenorphine/naloxone and HIV clinical care.
Sullivan LE; Barry D; Moore BA; Chawarski MC; Tetrault JM; Pantalon MV; O'Connor PG; Schottenfeld RS; Fiellin DA
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S184-90. PubMed ID: 17109305
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years.
Fiellin DA; Moore BA; Sullivan LE; Becker WC; Pantalon MV; Chawarski MC; Barry DT; O'Connor PG; Schottenfeld RS
Am J Addict; 2008; 17(2):116-20. PubMed ID: 18393054
[TBL] [Abstract][Full Text] [Related]
5. Thrice-weekly versus daily buprenorphine maintenance.
Schottenfeld RS; Pakes J; O'Connor P; Chawarski M; Oliveto A; Kosten TR
Biol Psychiatry; 2000 Jun; 47(12):1072-9. PubMed ID: 10862807
[TBL] [Abstract][Full Text] [Related]
6. Short-term buprenorphine maintenance: treatment outcome.
Galanter M; Dermatis H; Resnick R; Maslansky R; Neumann E
J Addict Dis; 2003; 22(3):39-49. PubMed ID: 14621343
[TBL] [Abstract][Full Text] [Related]
7. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.
Johnson RE; Eissenberg T; Stitzer ML; Strain EC; Liebson IA; Bigelow GE
Drug Alcohol Depend; 1995 Nov; 40(1):17-25. PubMed ID: 8746920
[TBL] [Abstract][Full Text] [Related]
8. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
[TBL] [Abstract][Full Text] [Related]
9. Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers.
Woodcock EA; Lundahl LH; Greenwald MK
Drug Alcohol Depend; 2015 Jan; 146():89-96. PubMed ID: 25479914
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.
Soeffing JM; Martin LD; Fingerhood MI; Jasinski DR; Rastegar DA
J Subst Abuse Treat; 2009 Dec; 37(4):426-30. PubMed ID: 19553061
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran.
Ahmadi J
J Subst Abuse Treat; 2002 Apr; 22(3):157-9. PubMed ID: 12039619
[TBL] [Abstract][Full Text] [Related]
12. Opioid abstinence reinforcement delays heroin lapse during buprenorphine dose tapering.
Greenwald MK
J Appl Behav Anal; 2008; 41(4):603-7. PubMed ID: 19192863
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
Ling W; Wesson DR; Charuvastra C; Klett CJ
Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.
Johnson RE; Eissenberg T; Stitzer ML; Strain EC; Liebson IA; Bigelow GE
Drug Alcohol Depend; 1995 Nov; 40(1):27-35. PubMed ID: 8746921
[TBL] [Abstract][Full Text] [Related]
15. Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial.
Chawarski MC; Mazlan M; Schottenfeld RS
Drug Alcohol Depend; 2008 Apr; 94(1-3):281-4. PubMed ID: 18164145
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine for human immunovirus-positive opiate-dependent patients.
Montoya ID; Umbricht A; Preston KL
Biol Psychiatry; 1995 Jul; 38(2):135-6. PubMed ID: 7578651
[No Abstract] [Full Text] [Related]
17. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?
Caldiero RM; Parran TV; Adelman CL; Piche B
Am J Addict; 2006; 15(1):1-7. PubMed ID: 16449087
[TBL] [Abstract][Full Text] [Related]
18. Transferring methadone-maintained outpatients to the buprenorphine sublingual tablet: a preliminary study.
Greenwald MK; Schuh KJ; Stine SM
Am J Addict; 2003; 12(4):365-74. PubMed ID: 14504028
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.
Comer SD; Walker EA; Collins ED
Psychopharmacology (Berl); 2005 Oct; 181(4):664-75. PubMed ID: 16025322
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of primary-care-based buprenorphine maintenance for heroin dependence.
O'Connor PG; Oliveto AH; Shi JM; Triffleman E; Carroll KM; Kosten TR; Rounsaville BJ
Am J Drug Alcohol Abuse; 1996 Nov; 22(4):523-31. PubMed ID: 8911590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
